References for: assertion
Full identifier: http://purl.org/np/RAOE99VP_HbvtZOrGDBDGP2izlwpCwpqohyOcubyj2CYI#assertion
| Nanopublication | Part | Subject | Predicate | Object | Published By | Published On |
|---|---|---|---|---|---|---|
|
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
assertion
|
Elif Ozkan
|
2022-10-13T12:18:06.846Z
|
|||
|
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
assertion
|
2022-10-13T12:18:06.846456
|
Elif Ozkan
|
2022-10-13T12:18:06.846Z
|
||
|
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
assertion
|
Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection. It is available in a combination product alongside dolutegravir and lamivudine for the. treatment of adult and pediatric patients with HIV--1 who weigh. 10 kg who weigh ≥10 kg are considered to be patients with the disease. Adults and children who weigh more than 10 kg are recommended to take the drug.
|
Elif Ozkan
|
2022-10-13T12:18:06.846Z
|